Nuwellis Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Nuwellis Inc.
Former names: CHF Solutions, Inc. Sunshine Heart, Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 3845 — Electromedical & Electrotherapeutic Apparatus
Jurisdiction of incorporation: Delaware
Headquarters city: Eden Prairie
Headquarters state / province: Minnesota
Headquarters country: United States
Fiscal year end: December
Ticker symbol: NUWE
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001506492
EIN: 68-0533453

Board of directors

Follow this board

Archelle Georgiou Feldshon · Director
Since 2023
David McDonald · Director
Since 2023
Gregory D. Waller · Director
Since 2023
John L. Erb · Director · CEO and President
Since 2023
Jon W. Salveson · Director
Since 2023
Katharyn Field · Director
Since 2026
Martin J. Emerson · Director
Since 2026
Michael Kendrick McCormick · Director · President and CEO
Since 2023
Mika Grasso · Director
Since 2026
Nestor Jaramillo Jr. · Director · President and CEO
Since 2023
Warren S. Watson · Director
Since 2023

Chief executives

Michael Kendrick McCormick · President and CEO

Since June 2026

Nestor Jaramillo Jr. · President and CEO

Until June 2026 · Former

John L. Erb · CEO and President

Until June 2026 · Former

Director election results

Annual meeting of April 28, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

David McDonald

83.9%
Martin J. Emerson

94.5%

Board connections

4 of this board's directors also sit on 5 other boards. 3 are in the same sector.

Shared director Other board Same sector

BioRestorative Therapies Inc. Same sector
via Katharyn Field and Mika Grasso
Arcadia Biosciences Inc.
via Gregory D. Waller
Artivion Inc. Same sector
via Jon W. Salveson
LogProstyle Inc.
via Katharyn Field
iSpecimen Inc. Same sector
via Katharyn Field

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Jun 10, 2025	John L. Erb Director, Officer (CEO and President), 10% owner	Derivative conversion	+7,522	$0.06	$451
Jun 9, 2025	John L. Erb Director, Officer (CEO and President), 10% owner	Derivative conversion	+1,092,500	$0.06	$65,550
Mar 15, 2023	Nestor Jaramillo Jr. Director, Officer (President and CEO)	Open-market purchase	+4,098	$4.79	$19,629

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Nuwellis Inc.

Who is the CEO of Nuwellis Inc.?

Michael Kendrick McCormick has been Nuwellis Inc.'s President and CEO since June 2026.

How many directors are on Nuwellis Inc.'s board?

Nuwellis Inc.'s board has 11 directors: Archelle Georgiou Feldshon, David McDonald, Gregory D. Waller, John L. Erb, Jon W. Salveson, Katharyn Field, Martin J. Emerson, Michael Kendrick McCormick, Mika Grasso, Nestor Jaramillo Jr. and 1 other.

How is Nuwellis Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="nuwellis-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.